The Jackson Laboratory–New York Stem Cell Foundation Collaborative (JAX-NYSCF) today announced a five-year strategic research collaboration with GSK focused on advancing human cellular models of ...
A phase IIa randomized trial found that intravenous dimethyltryptamine (DMT) with structured psychological support produced rapid reductions in depressive symptoms in adults with major depressive ...
February 18, 2026 • A study finds that people who did one specific form of brain training in the 1990s were less likely to be diagnosed with dementia over the next 20 years.